BioDelivery Sciences Current Ratio 2006-2021 | BDSI

BioDelivery Sciences current ratio from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
BioDelivery Sciences Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.20B $0.06B 3.07
2021-03-31 $0.19B $0.06B 3.41
2020-12-31 $0.18B $0.05B 3.44
2020-09-30 $0.17B $0.05B 3.16
2020-06-30 $0.16B $0.06B 2.81
2020-03-31 $0.13B $0.06B 2.19
2019-12-31 $0.12B $0.05B 2.18
2019-09-30 $0.11B $0.05B 2.25
2019-06-30 $0.10B $0.04B 2.34
2019-03-31 $0.07B $0.02B 2.88
2018-12-31 $0.07B $0.02B 3.07
2018-09-30 $0.07B $0.02B 3.00
2018-06-30 $0.07B $0.02B 3.16
2018-03-31 $0.03B $0.02B 1.40
2017-12-31 $0.04B $0.03B 1.52
2017-09-30 $0.04B $0.03B 1.28
2017-06-30 $0.04B $0.03B 1.45
2017-03-31 $0.05B $0.03B 1.78
2016-12-31 $0.04B $0.02B 2.20
2016-09-30 $0.06B $0.03B 1.74
2016-06-30 $0.07B $0.03B 2.37
2016-03-31 $0.08B $0.03B 2.64
2015-12-31 $0.09B $0.03B 3.30
2015-09-30 $0.06B $0.03B 2.34
2015-06-30 $0.07B $0.02B 3.58
2015-03-31 $0.07B $0.03B 2.43
2014-12-31 $0.08B $0.03B 2.67
2014-09-30 $0.09B $0.03B 2.59
2014-06-30 $0.09B $0.03B 3.20
2014-03-31 $0.09B $0.03B 3.58
2013-12-31 $0.03B $0.03B 1.06
2013-09-30 $0.04B $0.02B 1.62
2013-06-30 $0.04B $0.02B 1.85
2013-03-31 $0.05B $0.02B 2.49
2012-12-31 $0.06B $0.02B 2.75
2012-09-30 $0.03B $0.04B 0.81
2012-06-30 $0.04B $0.03B 1.28
2012-03-31 $0.03B $0.03B 1.26
2011-12-31 $0.01B $0.02B 0.62
2011-09-30 $0.02B $0.02B 0.84
2011-06-30 $0.02B $0.02B 1.04
2011-03-31 $0.03B $0.02B 1.14
2010-12-31 $0.02B $0.02B 0.86
2010-09-30 $0.02B $0.02B 1.16
2010-06-30 $0.03B $0.02B 1.45
2010-03-31 $0.02B $0.02B 0.99
2009-12-31 $0.03B $0.02B 1.08
2009-09-30 $0.03B $0.08B 0.35
2009-06-30 $0.01B $0.06B 0.10
2009-03-31 $0.00B $0.05B 0.07
2008-12-31 $0.00B $0.05B 0.03
2008-09-30 $0.01B $0.04B 0.19
2008-06-30 $0.01B $0.01B 1.21
2008-03-31 $0.01B $0.01B 1.43
2007-12-31 $0.02B $0.01B 1.20
2007-09-30 $0.02B $0.01B 1.51
2007-06-30 $0.00B $0.02B 0.10
2007-03-31 $0.00B $0.02B 0.08
2006-12-31 $0.00B $0.01B 0.20
2006-09-30 $0.00B $0.01B 0.61
2006-06-30 $0.01B $0.01B 1.02
2006-03-31 $0.01B $0.01B 0.72
2005-12-31 $0.01B $0.01B 1.11
2005-09-30 $0.00B $0.01B 0.16
2005-06-30 $0.00B $0.00B 0.66
2005-03-31 $0.00B $0.00B 0.82
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.408B $0.156B
BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any process, substance, or combination thereof, that delivers drugs into the body.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76